Source: FDA, National Drug Code (US) Revision Year: 2020
VERSACLOZ, an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine.
The structural formula is:
VERSACLOZ is available as a free-flowing yellow suspension. Each mL contains 50 mg of clozapine.
The active component of VERSACLOZ is clozapine. The remaining components are glycerin, sorbitol (crystallizing), sodium dihydrogen phosphate dihydrate, xanthan gum, sodium methylparaben, sodium propylparaben, povidone, water, and sodium hydroxide to adjust to a pH range of 6.5–7.0.
| Dosage Forms and Strengths |
|---|
|
VERSACLOZ is available as a free-flowing yellow oral suspension. Each mL contains 50 mg of clozapine. |
| How Supplied |
|---|
|
Oral Suspension. Free-flowing, yellow suspension (50 mg/mL) in amber bottle containing 100 mL. Each box contains 1 × 1 mL oral syringe, 1 × 9 mL oral syringe and 1 bottle adaptor. NDC No. 52817-601-38 Distributed by: TruPharma, LLC, Tampa, FL 33609 |
| Drug | Countries | |
|---|---|---|
| VERSACLOZ | Australia, New Zealand, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
